NNC0142-0002

DRUG2 trials

Sponsors

Janssen Research & Development, LLC

Conditions

InflammationRheumatoid Arthritis

Phase 1

First-in-man Trial of NNC0142-0002 in Patients With Rheumatoid Arthritis

CompletedNCT00927927

Janssen Research & Development, LLCInflammation, Rheumatoid Arthritis

Start: 2009-06-30End: 2011-12-31Updated: 2016-10-03

Phase 2

Efficacy of NNC0142-0002 in Subjects With Rheumatoid Arthritis (RA)

CompletedNCT01181050

Janssen Research & Development, LLCInflammation, Rheumatoid Arthritis

Start: 2010-08-31End: 2012-04-30Updated: 2016-10-03